The social, psychopathological and consumer context of rate of symptom improvement in acute mania

Jim van Os; Inge van Rossum; Maarten M. Boomsma; Eduard Vieta; Iris Goetz; Catherine Reed; Josep María Haro

doi:10.1007/s00127-007-0215-y

Related publications

Article2005

Risperidone in the treatment of acute mania

Sumant Khanna, Eduard Vieta, Benjamin Lyons, Fred Grossman, Mariëlle Eerdekens, Michelle Kramer

Article2004

Acute and continuation risperidone monotherapy in mania

Eduard Vieta, Esteve Brugué, José Manuel Goikolea, José Sánchez‐Moreno, María Reinares, Mercé Comes, Francesc Colom, Anabel Martínez‐Arán, Antoni Benabarre, Carla Torrent

Article2024

THE ROLE OF SOCIAL MARKETING IN COMBATING UNSUSTAINABLE CONSUMER BEHAVIOR AND FOOD WASTE

Manuela Apetrei, Ioan Surdu, Carmen Cătună Boca

Article2024

THE ROLE OF SOCIAL MARKETING IN COMBATING UNSUSTAINABLE CONSUMER BEHAVIOR AND FOOD WASTE

Manuela Apetrei, Ioan Surdu, Carmen Cătună Boca

Article2003

Olanzapine Versus Placebo in Acute Mania

Ross J. Baldessarini, John Hennen, Michael G. Wilson, Joseph R. Calabrese, Roy Chengappa, Paul E. Keck, Susan L. McElroy, Gary Sachs, Eduard Vieta, Jeffrey A. Welge, Lakshmi N. Yatham, Carlos A. Zarate, Robert W. Baker, Mauricio Tohen

The social, psychopathological and consumer context of rate of symptom improvement in acute mania

Discussion(0)

Related publications

Risperidone in the treatment of acute mania

Acute and continuation risperidone monotherapy in mania

THE ROLE OF SOCIAL MARKETING IN COMBATING UNSUSTAINABLE CONSUMER BEHAVIOR AND FOOD WASTE

THE ROLE OF SOCIAL MARKETING IN COMBATING UNSUSTAINABLE CONSUMER BEHAVIOR AND FOOD WASTE

Olanzapine Versus Placebo in Acute Mania